Nothing about long Covid adds up, and a closer look reveals a confusing patchwork of conflicting data, treatment recommendations, and scientific progress—or lack thereof.

The prevalence of long Covid varies wildly between studies, from 3.3% in the UK to alarming rates like 51% among South Americans and 86% in Egypt. The evidence for effective treatments is scant: cognitive behavioural therapy and physical exercise, according to a BMJ review, yet at the Long Covid International Conference, experts seemed to warn against these very treatments.

Despite six years of research, researchers still struggle to understand why some recover while others remain bedridden. Even after investing almost $2 billion, their findings boil down to hypotheses about micro blood clots and mitochondrial dysfunction. The lack of approved pharmaceuticals or diagnostic tests is both frustrating and concerning for patients like Andrew Larson.

For Larson, a recovery process outside mainstream medicine offered marginal relief. His story resonates with thousands who find themselves dismissed by sceptical specialists and burdened by persistent and debilitating symptoms. Yet, his case also highlights the potential of alternative approaches that challenge conventional wisdom.